Occupational Therapists in Drexel Hill, PA Accepting Medicare

7 Occupational Therapists found. Showing 1 - 7

Nadine Hepburn, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2415 Marshall Rd, Drexel Hill, PA 19026 Phone: 610-626-4288

Megan Smith O'sullivan, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1312 Center Rd, Drexel Hill, PA 19026 Phone: 610-761-7644

Michelle Salera Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3440 Valley Green Dr, Drexel Hill, PA 19026 Phone: 800-578-7906    Fax: 800-878-5497

Chelsea Gibson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 927 Stanbridge Rd, Drexel Hill, PA 19026 Phone: 610-457-1903

Samantha Mitchell Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1217 Agnew Dr, Drexel Hill, PA 19026 Phone: 610-389-0858

Grace Scorzetti, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 829 Wilde Ave, Drexel Hill, PA 19026 Phone: 610-716-0247

Michelle Schwartz Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3300 Township Line Rd, Drexel Hill, PA 19026 Phone: 610-853-9919

News Archive

People with severe asthma are less likely to respond to treatment

Barcelona, Spain: People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.

CREST, ARUBA give long-term updates

Today's late-breaking trials session at the International Stroke Conference featured the long-term results of CREST and ARUBA, both of which support the original trial findings.

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment of non-small cell lung cancer (NSCLC).

Drug coated balloons are as good as stent implants for treating small blocked arteries

A removable balloon is as good as a permanent stent implant for opening small blocked arteries, according to late breaking results from the BASKET-SMALL 2 trial presented in a Hot Line Session today at ESC Congress 2018 and simultaneously published in The Lancet.

Arrowhead receives FDA IND approval for Adipotide obesity drug

Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.

Read more Medical News

› Verified 1 days ago